Skip to Main Content

COVID-19 Feature Articles: Issue 89 January 20

A guide that lists selected articles regarding COVID-19 relevant to SVHA

COVID-19 Feature Articles

This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.

All articles listed are open access unless stated otherwise.


COVID-19 therapeutics for nonhospitalized patients.
JAMA:2022: January 14 Full text

Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized clinical trial.
JAMA:2022: January 14 
Full text

Usefulness of combined renin-angiotensin system inhibitors and diuretic treatment in patients hospitalized with COVID-19.
American Journal of Cardiology:2022: January 10 Full text

Clinical Practice

Perioperative cardiovascular considerations prior to elective noncardiac surgery in patients with a history of COVID-19.
JAMA Surgery:2022: January 10 Full text

Assessment of functional mobility after COVID-19 in adults aged 50 years or older in the Canadian Longitudinal Study on Aging.
JAMA Network Open:2022: January 12 Full text

Clinical profile and recovery pattern of dysphagia in the COVID-19 patient: a prospective observational cohort within NSW. AUS
Australian Critical Care:2022: January 14 Full text

Evaluating immunity to SARS-CoV-2 in nursing home residents using saliva IgG.
Journal of the American Geriatrics Society:2022: January 17 Full text


Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years — United States, March 1, 2020–June 28, 2021.
Morbidity and Mortality Weekly Report (MMWR):2022: January 7 Full text

SARS-CoV-2 adipose tissue infection and hyperglycemia: a further step towards the understanding of severe COVID-19.
Metabolism Open:2022: January 13 Full text

Long Covid

Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain.
bioRxiv:2022: January 10 Full text

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection.
Nature Immunology:2022: January 13 Full text

Infection Control

Practical indicators for risk of airborne transmission in shared indoor environments and their application to COVID-19 outbreaks.
Environmental Science and Technology:2022: January 5 Full text

Surgical helmets can be converted into efficient disinfectable powered air-purifying respirators.
American Journal of Infection Control:2021: December 25 Full text


Association of a third dose of BNT162b2 vaccine with incidence of SARS-CoV-2 infection among health care workers in Israel.
JAMA:2022: January 10 Full text

Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021.
medRxiv:2022: January 17 Full text


Ancestral SARS-CoV-2-specific T cells cross-recognize Omicron.
Nature Medicine:2022: January 14 Full text

Resilient T cell responses to B.1.1.529 (Omicron) SARS-CoV-2 variant.
medRxiv:2022: January 16 Full text

Chief Librarian - St Vincent's Hospital, Melbourne

Profile Photo
Jeremy Taylor
03 9231 2542